Susan H Julien

Title: Innovations and Contributions of Susan H Julien

Introduction

Susan H Julien is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of biotechnology. With a total of four patents to her name, she has made remarkable strides in the development of therapeutic antibodies.

Latest Patents

One of her latest patents focuses on antibodies to TIGIT, a T cell immunoreceptor with Ig and ITIM domains. This invention provides antibodies or antigen-binding fragments that bind to human TIGIT, with applications in treating cancer and chronic viral infections. The methods of treatment include combination therapy with inhibitors of other immunomodulatory receptor interactions, such as the PD-1/PD-L1 interaction. Additionally, the invention encompasses polynucleotides encoding the heavy and/or light chain variable region of the antibodies, expression vectors comprising these polynucleotides, and methods for producing the antibodies or fragments by expressing them from cells.

Career Highlights

Throughout her career, Susan has worked with notable companies, including Bristol-Myers Squibb Company and Zymogenetics, Inc. Her work has significantly impacted the development of innovative therapeutic solutions in the biotechnology sector.

Collaborations

Susan has collaborated with esteemed colleagues, including Mark F Maurer and Tseng-hui Timothy Chen, contributing to the advancement of her research and innovations.

Conclusion

Susan H Julien's work exemplifies the spirit of innovation in biotechnology, particularly in the development of therapeutic antibodies. Her contributions continue to influence the field and pave the way for future advancements.